Newly appointed ScinoPharm Taiwan Ltd (台灣神隆) president Tony Su (蘇崇銘) yesterday said that he would oversee the company’s transition amid immense changes in global markets and supply chains.
“My first responsibility at the company would be to oversee continuation of organizational restructuring and cost management,” Su told an earnings conference.
He said that the global market for generic drugs has been reshuffled by rapid consolidation and the company faces increasing challenges as prices trend lower.
Apart from changing its chief financial and research and development officers, there has not been a major shift in the management team, although key executives would take on additional roles to better align them with the company’s objectives, Su said.
Su was previously with Uni-President Enterprises Corp (UPE, 統一企業), a major investor in ScinoPharm.
ScinoPharm, which makes active pharmaceutical ingredients (APIs), as well as providing contract manufacturing and research services, said that it would begin to see profit contribution from a newly approved generic oncology injection that was developed with US-based Sagent Pharmaceutical Inc.
ScinoPharm said that its generic version of anti-thrombotic drug Fondaparinux in March gained approval from the US Food and Drug Administration and is to begin sales in the US in two to three months time.
The anti-thrombotic drug is also expected to gain market approval from Indian authorities and commence sales there this year, the company said.
This year, ScinoPharm has gained regulatory approval in China to supply generic APIs for a treatment for benign prostatic hyperplasia and a generic oncology injectible for myeloid leukemia in the US.
The company has observed a significant shift in China’s API supply chain as Beijing tightens environmental requirements, ScinoPharm marketing and sales vice president Portia Lin (林靜雯) said.
China has been ordering noncompliant manufacturers to shut down, leading to disruptions in the supply and pricing of chemicals, Lin said.
The company has minimized the disruption by importing from other markets, Lin said, adding that China’s new plant inspection regimen and stricter drug license approvals should help push out low-quality API suppliers.
The company reported that net income in the second quarter dipped 3 percent quarterly to NT$131 million (US$4.27 million), although revenue rose 14 percent to NT$986 million on the back of strong sales of colorectal cancer products. Earnings per share (EPS) were NT$0.17.
In the April-to-June period, gross margin and operating margin were 43 percent and 16 percent respectively, up from 39 percent and 14 percent in the previous period.
Overall, net income in the first half rose 5 percent annually to NT$267 million, or EPS of NT$0.34, while sales gained 4 percent to reach NT$1.85 billion.
SETBACK: Apple’s India iPhone push has been disrupted after Foxconn recalled hundreds of Chinese engineers, amid Beijing’s attempts to curb tech transfers Apple Inc assembly partner Hon Hai Precision Industry Co (鴻海精密), also known internationally as Foxconn Technology Group (富士康科技集團), has recalled about 300 Chinese engineers from a factory in India, the latest setback for the iPhone maker’s push to rapidly expand in the country. The extraction of Chinese workers from the factory of Yuzhan Technology (India) Private Ltd, a Hon Hai component unit, in southern Tamil Nadu state, is the second such move in a few months. The company has started flying in Taiwanese engineers to replace staff leaving, people familiar with the matter said, asking not to be named, as the
The prices of gasoline and diesel at domestic fuel stations are to rise NT$0.1 and NT$0.4 per liter this week respectively, after international crude oil prices rose last week, CPC Corp, Taiwan (台灣中油) and Formosa Petrochemical Corp (台塑石化) announced yesterday. Effective today, gasoline prices at CPC and Formosa stations are to rise to NT$27.3, NT$28.8 and NT$30.8 per liter for 92, 95 and 98-octane unleaded gasoline respectively, the companies said in separate statements. The price of premium diesel is to rise to NT$26.2 per liter at CPC stations and NT$26 at Formosa pumps, they said. The announcements came after international crude oil prices
STABLE DEMAND: Delta supplies US clients in the aerospace, defense and machinery segments, and expects second-half sales to be similar to the first half Delta Electronics Inc (台達電) expects its US automation business to remain steady in the second half, with no signs of weakening client demand. With demand from US clients remaining solid, its performance in the second half is expected to be similar to that of the first half, Andy Liu (劉佳容), general manager of the company’s industrial automation business group, said on the sidelines of the Taiwan Automation Intelligence and Robot Show in Taipei on Wednesday. The company earlier reported that revenue from its automation business grew 7 percent year-on-year to NT$27.22 billion (US$889.98 million) in the first half, accounting for 11 percent
A German company is putting used electric vehicle batteries to new use by stacking them into fridge-size units that homes and businesses can use to store their excess solar and wind energy. This week, the company Voltfang — which means “catching volts” — opened its first industrial site in Aachen, Germany, near the Belgian and Dutch borders. With about 100 staff, Voltfang says it is the biggest facility of its kind in Europe in the budding sector of refurbishing lithium-ion batteries. Its CEO David Oudsandji hopes it would help Europe’s biggest economy ween itself off fossil fuels and increasingly rely on climate-friendly renewables. While